Free Webinar: Italfarmaco Givinostat Development Program Update

The webinar will review the Italfarmaco Givinostat development program for Duchenne and Becker Muscular Dystrophy. Content that will be covered, includes:

Updates from the EPIDYS Study, a phase 3 clinical trial of Givinostat in ambulatory boys with DMD.
Data from Italfarmaco’s long term studies of Givinostat in DMD populations.
30 minute Q & A.

Paolo Bettica, MD, PhD Vice President of Research and Development, Italfarmaco S.p.A
Michael Kelly, Chief Scientific Advisor, CureDuchenne
Ana Christensen, Patient Science Liaison, TRINDS

Related Posts

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.